Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930
Clinical trial NCT05207761 · COMPLETED
Trial details
- NCT number
- NCT05207761
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2022-10-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.